SCHEMBL753119

SCHEMBL753119

Cc1cnc([C@](O)([C@H](C)c2ccc(OCc3ccc(C(=O)O)cc3Cl)cc2Cl)C(F)(F)F)cn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 4/20 0.44
NR4A1 P22736 1/20 0.40
NR4A3 Q92570 1/20 0.40
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
MRGPRX4 Q96LA9 4/20 0.36
SLC26A4 O43511 1/20 0.35
POLB P06746 1/20 0.35
NR1H4 Q96RI1 2/20 0.35
SRD5A2 P31213 2/20 0.35
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
KDM4A O75164 1/20 0.34
KDM5A P29375 1/20 0.34
KDM2B Q8NHM5 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
GCK P35557 1/20 0.34
PPARD Q03181 1/20 0.34
FFAR1 O14842 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL479913 1.00 NR4A2 (0.44) NR4A2NR4A1NR4A3NPC1RAB9A
SCHEMBL479990 0.92 HDAC8 (0.43) NR4A2NR4A1NR4A3MRGPRX4NR1H4
SCHEMBL754294 0.92 HDAC8 (0.43) NR4A2NR4A1NR4A3MRGPRX4NR1H4
SCHEMBL754290 0.92 NR4A2 (0.36) NR4A2MRGPRX4NR1H4
SCHEMBL479600 0.92 NR4A2 (0.36) NR4A2MRGPRX4NR1H4
SCHEMBL15800813 0.91 NR4A2 (0.39) NR4A2NR4A1NR4A3NPC1RAB9A
SCHEMBL733155 0.91 RXRA (0.44) NR4A2NPC1RAB9AMRGPRX4POLB
SCHEMBL479988 0.91 RXRA (0.44) NR4A2NPC1RAB9AMRGPRX4POLB
SCHEMBL733547 0.91 RXRA (0.44) NR4A2NPC1RAB9AMRGPRX4POLB
SCHEMBL479949 0.89 ALDH1A1 (0.39) MRGPRX4POLBSRD5A2RXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-8138189-B2 Substituted benzene compounds as modulators of the glucocorticoid receptor HOFFMAN-LA ROCHE INC. (US) 2012-03-20 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS HOFFMANN-LA ROCHE, INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249139-A1 1,1,1-TRIFLUORO-2-HYDROXYPROPYL COMPOUNDS NR3C1, NR3C2, CRHR1 NR4A2 220/4885NR4A1 92/4885NR4A3 234/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.